Cargando…

Interferon and autoantigens: intersection in autoimmunity

Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature autoantibody production, such as SLE, Sjögren’s syndrome, myositis and systemic sclerosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Antiochos, Brendan, Casciola-Rosen, Livia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203243/
https://www.ncbi.nlm.nih.gov/pubmed/37228405
http://dx.doi.org/10.3389/fmed.2023.1165225
_version_ 1785045589748088832
author Antiochos, Brendan
Casciola-Rosen, Livia
author_facet Antiochos, Brendan
Casciola-Rosen, Livia
author_sort Antiochos, Brendan
collection PubMed
description Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature autoantibody production, such as SLE, Sjögren’s syndrome, myositis and systemic sclerosis. Interestingly, many of the autoantigens targeted in these diseases are components of the IFN system, representing IFN-stimulated genes (ISGs), pattern recognition receptors (PRRs), and modulators of the IFN response. In this review, we describe features of these IFN-linked proteins that may underlie their status as autoantigens. Note is also made of anti-IFN autoantibodies that have been described in immunodeficiency states.
format Online
Article
Text
id pubmed-10203243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102032432023-05-24 Interferon and autoantigens: intersection in autoimmunity Antiochos, Brendan Casciola-Rosen, Livia Front Med (Lausanne) Medicine Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature autoantibody production, such as SLE, Sjögren’s syndrome, myositis and systemic sclerosis. Interestingly, many of the autoantigens targeted in these diseases are components of the IFN system, representing IFN-stimulated genes (ISGs), pattern recognition receptors (PRRs), and modulators of the IFN response. In this review, we describe features of these IFN-linked proteins that may underlie their status as autoantigens. Note is also made of anti-IFN autoantibodies that have been described in immunodeficiency states. Frontiers Media S.A. 2023-05-09 /pmc/articles/PMC10203243/ /pubmed/37228405 http://dx.doi.org/10.3389/fmed.2023.1165225 Text en Copyright © 2023 Antiochos and Casciola-Rosen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Antiochos, Brendan
Casciola-Rosen, Livia
Interferon and autoantigens: intersection in autoimmunity
title Interferon and autoantigens: intersection in autoimmunity
title_full Interferon and autoantigens: intersection in autoimmunity
title_fullStr Interferon and autoantigens: intersection in autoimmunity
title_full_unstemmed Interferon and autoantigens: intersection in autoimmunity
title_short Interferon and autoantigens: intersection in autoimmunity
title_sort interferon and autoantigens: intersection in autoimmunity
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203243/
https://www.ncbi.nlm.nih.gov/pubmed/37228405
http://dx.doi.org/10.3389/fmed.2023.1165225
work_keys_str_mv AT antiochosbrendan interferonandautoantigensintersectioninautoimmunity
AT casciolarosenlivia interferonandautoantigensintersectioninautoimmunity